青光眼患者白内障术后局部降压药预防眼压升高的效果
一项随机临床研究纳入165眼(原发性开角型或假性剥脱性青光眼)行超声乳化术,术后即刻分别给予曲伏前列素、噻吗洛尔或布林佐胺。布林佐胺组在术后4、6、8小时平均眼压显著低于另两组,眼压骤升(>25 mmHg)发生率也显著更低,提示布林佐胺预防术后短期眼压骤升更有效。
要点
- 布林佐胺组术后4、6、8小时平均眼压显著低于曲伏前列素和噻吗洛尔组。
- 三组术后2小时和24小时平均眼压无显著差异。
核心结论
- 在青光眼患者白内障术后,布林佐胺比曲伏前列素或噻吗洛尔更有效地降低短期眼压升高,提示布林佐胺更适合预防眼压骤升。
研究设计与样本
- 随机临床研究,纳入165例165眼原发性开角型青光眼或假性剥脱性青光眼行超声乳化术的患者,随机分为曲伏前列素组、噻吗洛尔组和布林佐胺组,术后即刻给药。
主要发现
- 术前1小时和手术结束时各组平均眼压无显著差异。
- 所有组平均眼压在术后4至8小时显著升高,24小时下降(P < .0001)。
- 布林佐胺组在术后4、6、8小时平均眼压显著低于曲伏前列素组和噻吗洛尔组(P ≤ .0374)。
- 术后2小时和24小时各组平均眼压无显著差异。
- 布林佐胺组眼压骤升(>25 mmHg)发生率显著低于曲伏前列素组和噻吗洛尔组(P = .0029)。
关键数值与推荐
- 眼压骤升定义为眼压大于25 mmHg。
- 使用回弹式眼压计在术前1小时、手术结束时及术后2、4、6、8、24小时测量眼压。
临床怎么用
- 对青光眼患者行白内障术后,可优先考虑局部使用布林佐胺以预防术后短期眼压骤升。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To compare the effects of a topical intraocular pressure (IOP)-lowering medication for preventing an IOP increase after cataract surgery in eyes with glaucoma. DESIGN: Randomized clinical study. METHODS: A total of 165 eyes of 165 patients with primary open-angle glaucoma or pseudoexfoliation glaucoma scheduled for phacoemulsification were randomly assigned to 1 of 3 groups to receive each medication immediately postoperatively: 1) prostaglandin F2α analog (travoprost), 2) β-blocker (timolol maleate), or 3) carbonic anhydrase inhibitor (brinzolamide). Intraocular pressure (IOP) was measured using a rebound tonometer at 1 hour preoperatively, at the end of surgery, and at 2, 4, 6, 8, and 24 hours postoperatively. The incidence of eyes exhibiting a marked IOP increase to greater than 25 mm Hg was compared among the groups. RESULTS: At 1 hour preoperatively and at the end of surgery, mean IOP did not differ significantly among the groups. Mean IOP increased significantly between 4 and 8 hours postoperatively and then decreased at 24 hours postoperatively in all groups (P < .0001). Mean IOP was significantly lower in the brinzolamide group than in the travoprost or timolol group at 4, 6, and 8 hours postoperatively (P ≤ .0374) and did not differ significantly among groups at 2 and 24 hours postoperatively. The incidence of an IOP spike was significantly lower in the brinzolamide group than in the travoprost and timolol groups (P = .0029). CONCLUSIONS: Brinzolamide reduces the short-term IOP increase after cataract surgery more effectively than travoprost or timolol in eyes with glaucoma, suggesting that brinzolamide is preferable for preventing an IOP spike.
引用
- Hayashi K, Yoshida M, Sato T, et al. Effect of Topical Hypotensive Medications for Preventing Intraocular Pressure Increase after Cataract Surgery in Eyes with Glaucoma. Am J Ophthalmol. 2019. PMID: 30902694. doi:10.1016/j.ajo.2019.03.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。